2024 ASCO GI Cancers Symposium
The 2024 American Society of Clinical Oncology GI Cancers Symposium, which took place January 18-20, 2024, provides the latest updates on gastrointestinal cancer treatment, research, and care. It features panel discussions, presentations, poster sessions, and more opportunities to learn about innovations, solutions, and multidisciplinary approaches.
An online quiz provided over 30,000 CRC screening recommendations from July 2022-August 2023.
Timothy Brown, MD, discusses research on the treatment strategy at the 2024 ASCO GI Cancers Symposium.
MATTERHORN is the “first study to attempt to standardize therapy perioperatively with FLOT,” Dr. Janjigian said.
Jessica A. Zerillo, MD, MPH, discusses research on the tool that she presented at the 2024 ASCO GI Cancer Symposium.
Martha Raymond, MA, discusses eye-opening findings from a study presented at the 2024 ASCO GI Cancers Symposium.
Researchers wanted to understand how patients perceive the utility of ctDNA testing and how it affects fear of recurrence.
New research shows why the importance of addressing malnutrition in patients with GI cancer "cannot be overstated."
A combined analysis of SPOTLIGHT and GLOW showed nausea occurred in 58% of patients with the first infusion of zolbetuximab.
The study suggests that leaving the primary undetectable tumor in situ until local regrowth may result in worse outcomes.
Advertisement
Advertisement
